Piper Sandler Maintains Overweight on Cigna Group, Raises Price Target to $370
Piper Sandler analyst Jessica Tassan maintains Cigna Group (NYSE:CI) with a Overweight and raises the price target from $346 to $370.
Stocks · News reference
Robert Kennedy Jr. Pushes New Healthcare Pricing Rules as HHS Says Patients Deserve Clearer Costs: ‘Americans Should Know…’
HHS and CMS finalize new healthcare price transparency rules, requiring quarterly pricing reports and phone-based cost estimates.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
RBC Capital Reiterates Outperform on Cigna Group, Maintains $337 Price Target
Cigna Sets Long-Term Goals, Unveils 2030 Modernization Strategy
Cigna unveils its Lead to One vision, reaffirms 2026 financial targets, and sets a $3 billion modernization plan.
UnitedHealthcare, Aetna Tighten Medicare Advantage Networks as 2027 Costs Rise: ‘We Can’t Ignore the Realities…’
UnitedHealthcare and Aetna plan tighter Medicare Advantage networks by 2027 as costs rise, while premiums fall.
Cardinal Health, McKesson Double Down on CVS Deals Through 2032
Cardinal Health and McKesson extend drug distribution deals with CVS Health through June 2032, reaffirming FY2027 adjusted earnings guidance.
Cardinal Health Enters Into Binding LOI To Extend Existing Distribution Agreement With CVS Health Through June 30, 2032